Subscribe: Biotech-Healthcare/Biotech-News By Industry-News-The Economic Times
http://economictimes.indiatimes.com/rssfeeds/13358090.cms
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
biocon  biologic products  biosimilar  biotech  company  dcgi nod  drug  monsanto  mylan  new  product  proposed biosimilar  proposed 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotech-Healthcare/Biotech-News By Industry-News-The Economic Times

Biotech-Healthcare/Biotech-Industry-The Economic Times



The Economic Times: Latest business, finance, markets, stocks, company news from India.



Last Build Date: Sun, 23 Apr 2017 21:49:29 GMT

Copyright: Copyright:(C)2017 Bennett Coleman & Co. Ltd, http://info.indiatimes.com/terms/tou.html
 



"Indian drug regulator wants patients to report adverse effects of Abbott BVS"

Mon, 10 Apr 2017 19:21:31 GMT

(image) BVS used as an implant during an angioplasty procedure is a tube device that clears blockages in arteries that carry blood to the heart which dissolves over time.



USFDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim

Fri, 17 Feb 2017 10:42:50 GMT

(image) The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the two companies said in a statement.



Biocon bags Rs 460-crore contract from Malaysia

Wed, 25 Jan 2017 07:06:02 GMT

(image) The drug, manufactured by Biocon at its large scale biopharmaceutical facility in Johor, Malaysia, is the country's first locally manufactured.



Norms eased for makers of biologic products

Fri, 16 Dec 2016 19:35:12 GMT

(image) CDSCO has done away with the need for joint inspections to issue licences to allow such companies to make biologic products for testing and analysis purposes.



Carlyle Group emerges front-runner for Bharat Biotech stake

Thu, 04 Aug 2016 10:45:14 GMT

(image) The firm counts domestic private equity fund ICICI Ventures, International Finance Corp, the global investment arm of the World Bank and Subhkam Ventures as its investors.



EMA accepts marketing application of Biocon, Mylan product

Thu, 21 Jul 2016 16:00:38 GMT

(image) Mylan and Biocon, who co-developed the proposed biosimilar, received EMA's acceptance of the submission for review, Biocon said in a statement.



Monsanto to consider Bayer's revised proposal for acquisition

Fri, 15 Jul 2016 14:49:06 GMT

(image) Bayer had raised its all-cash offer to Monsanto shareholders from $ 122 to $ 125/share. It also offered a $ 1.5-billion reverse anti-trust break fee.



Biocon's partner firm launches diabetes product in Japan

Fri, 15 Jul 2016 07:19:24 GMT

(image) In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.



West Bengal to set up three biotechnology hubs

Thu, 07 Jul 2016 12:25:34 GMT

(image) Biotechnology Dept of the State has already taken up an elaborate scheme to not only tie up with other departments like Agriculture, Fisheries and Food Processing.



Biocon, Quark get DCGI nod for trials of new eye disease drug

Thu, 23 Jun 2016 07:08:50 GMT

(image) Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy."



GEAC defers decision on commercial cultivation of GM mustard

Mon, 20 Jun 2016 16:58:13 GMT

(image) Biotech regulator GEAC today deferred its decision on commercial cultivation of genetically modified (GM) mustard in the country.



New drug, vaccines to get booster dose from government

Tue, 07 Jun 2016 01:48:20 GMT

(image) DBT is looking to invest in a programme to expand the existing centres for drug and vaccine research which will take up the possibility of investing.



Stempeutics research gets DCGI nod for stem cell based product

Mon, 30 May 2016 08:42:52 GMT

(image) The company's goal is to globalise Stempeucel for Buerger's Disease and the market size is approximately $ 1.5 billion worldwide.



Government puts off GM cotton seed order, eases pressure on Monsanto

Mon, 23 May 2016 16:06:00 GMT

(image) In an order last week, the farm ministry said any company providing any new, advanced variety of GM cotton would not be allowed to charge royalties.



Modi government puts a sales squeeze on world's biggest seed company Monsanto

Sat, 21 May 2016 05:23:20 GMT

(image) The move will cap royalties for any new variety that the market's sole supplier - US-based Monsanto Co - decides to develop and sell.